America Great Health AAGH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.03
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $17.41 Mil
- Volume/Avg
- 30.0 Mil / 6.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 102.00
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
America Great Health operates as a biotechnology company. The company focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerative medicine and supplements, as well as invests in technologies and integrates with business development for the healthcare ecosystem.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 7
- Website
- http://www.aaghus.com
Comparables
Valuation
Metric
|
AAGH
|
PTGX
|
LYEL
|
---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | — | 4.31 | 0.84 |
Price/Sales | 102.00 | 23.79 | 4,189.19 |
Price/Cash Flow | — | — | — |
Price/Earnings
AAGH
PTGX
LYEL
Financial Strength
Metric
|
AAGH
|
PTGX
|
LYEL
|
---|---|---|---|
Quick Ratio | 0.03 | 16.54 | 15.82 |
Current Ratio | 0.08 | 16.71 | 16.07 |
Interest Coverage | −1.37 | — | — |
Quick Ratio
AAGH
PTGX
LYEL
Profitability
Metric
|
AAGH
|
PTGX
|
LYEL
|
---|---|---|---|
Return on Assets (Normalized) | −281.13% | −16.60% | −20.62% |
Return on Equity (Normalized) | — | −18.20% | −23.35% |
Return on Invested Capital (Normalized) | — | −23.45% | −24.46% |
Return on Assets
AAGH
PTGX
LYEL
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Znfrzllqv | Xvyl | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Rbwvqxys | Ptwpkd | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Bnvsbkqfm | Gmqnmj | $97.8 Bil | |
MRNA
| Moderna Inc | Gbnglpbrx | Zbxp | $41.3 Bil | |
ARGX
| argenx SE ADR | Wlpxtxyn | Lbc | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Zzzzrlrb | Tdww | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Ssgbjlnxj | Ntbhct | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Rjzshkn | Wdjwdfl | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Zwccwlbt | Djxpchn | $12.5 Bil | |
INCY
| Incyte Corp | Fdmvcbpx | Mzfzpk | $11.6 Bil |